Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_assertion type Assertion NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_head.
- NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_assertion description "[At least one of the four genes was methylated in 76% of the tumors; (b) a low frequency of methylation was present in nonmalignant tissues; (c) no significant differences in methylation frequencies were seen between the nonmalignant ovarian tissues from women at high-risk and those with no known risk of developing ovarian cancer; (d) methylation of the BRCA1 gene was found in 10% of sporadic tumors but in none of the samples from women with a germ-line BRCA1 mutation; and (e) ovarian cancer cell lines showed a similar frequency of methylation to ovarian tumors except for the HIC1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_provenance.
- NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_assertion evidence source_evidence_literature NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_provenance.
- NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_assertion SIO_000772 12429618 NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_provenance.
- NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_assertion wasDerivedFrom befree-20140225 NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_provenance.
- NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_assertion wasGeneratedBy ECO_0000203 NP455286.RANq9jG-aog_UplyWDAcU9Z7Urc6G2hFfdbtgTrEBUuMo130_provenance.